About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Aug 4, 2020 7:54 am | Healthcare Market Updates
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date... Read More »
by Dylan Sammut | Jul 28, 2020 8:57 am | Healthcare Market Updates
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date... Read More »
by Dylan Sammut | Jul 28, 2020 8:28 am | Physician Medical Groups
GI Alliance announced two new acquisitions in Illinois last week. With the backing of private equity firm Waud Capital Partners, the company has expanded nationwide quickly, announcing nearly 10 transactions since early 2019, according to DSO. And GI Alliance... Read More »
by Dylan Sammut | Jul 28, 2020 8:25 am | eHealth
DXC Technology (NYSE: DXC) has spent 2020 trying to streamline its business portfolio. When Mike Salvino took over as CEO of DXC in September 2019, he announced during his first earnings call that the company was planning strategic alternatives, including the... Read More »
by Dylan Sammut | Jul 28, 2020 8:23 am | Biotechnology
AstraZeneca plc (NYSE: AZN) has struck a new global development and commercialization agreement with Daiichi Sankyo Company (OTCMKTS: SKYF) that could be worth up to $6 billion. The agreement focuses on DS-1062, Daiichi Sankyo’s proprietary trophoblast cell-surface... Read More »